Sunday, April 19, 2020

Cancer drug resistance study raises immune red flags

Once a cancer patient's tumors develop resistance to chemotherapy, the prognosis can be poor. However, inhibiting a key gene involved in multidrug resistance, MDR1, has not improved outcomes. A new study offers a reason, revealing unintended downstream effects on immune system cells.

from Latest Science News -- ScienceDaily https://ift.tt/2VKXwIV
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reverse liver cell aging and cut Alzheimer’s-linked protein in half

A surprising discovery suggests that rejuvenating the liver could help protect against Alzheimer’s disease and heart disease. USC researcher...